{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T02:36:53Z","timestamp":1781491013784,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-107-2320-B-182A-022"],"award-info":[{"award-number":["MOST-107-2320-B-182A-022"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3H0011"],"award-info":[{"award-number":["CMRPG3H0011"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adverse reactions may still occur in some patients after receiving haematopoietic stem cell transplantation (HSCT), even when choosing a human leukocyte antigen (HLA)-matched donor. The adverse reactions of transplantation include disease relapse, graft-versus-host disease (GVHD), mortality and CMV infection. However, only the relapse was discussed in our previous study. Therefore, in this study, we investigated the correlation between the gene polymorphisms within the HLA region and the adverse reactions of post-HSCT in patients with acute leukaemia (n\u2009=\u2009176), where 72 patients were diagnosed with acute lymphocytic leukaemia (ALL) and 104 were acute myeloid leukaemia (AML). The candidate single nucleotide polymorphisms were divided into three models: donor, recipient, and donor-recipient pairs and the data of ALL and AML were analysed individually. Based on the results, we found 16 SNPs associated with the survival rates, the risk of CMV infection, or the grade of GVHD in either donor, recipient, or donor-recipient matching models. In the ALL group, the rs209132 of TRIM27 in the donor group was related to CMV infection (p\u2009=\u20090.021), the rs213210 of RING1 in the recipient group was associated with serious GVHD (p\u2009=\u20090.003), and the rs2227956 of HSPA1L in the recipient group correlated with CMV infection (p\u2009=\u20090.001). In the AML group, the rs3130048 of BAG6 in the donor-recipient pairs group was associated with serious GVHD (p\u2009=\u20090.048). Moreover, these SNPs were further associated with the duration time of survival after transplantation. These results could be applied to select the best donor in HSCT.<\/jats:p>","DOI":"10.1038\/s41598-020-79369-w","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T06:03:13Z","timestamp":1610604193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The adverse events of haematopoietic stem cell transplantation are associated with gene polymorphism within human leukocyte antigen region"],"prefix":"10.1038","volume":"11","author":[{"given":"Ding-Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ling","family":"Hour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Tzu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ping","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"79369_CR1","first-page":"149","volume":"4","author":"GC Yee","year":"1985","unstructured":"Yee, G. C. & McGuire, T. R. Allogeneic bone marrow transplantation in the treatment of hematologic diseases. Clin Pharm. 4, 149\u2013160 (1985).","journal-title":"Clin Pharm."},{"key":"79369_CR2","first-page":"209","volume":"5","author":"K Atkinson","year":"1990","unstructured":"Atkinson, K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant. 5, 209\u2013226 (1990).","journal-title":"Bone Marrow Transplant."},{"key":"79369_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/sji.12329","volume":"82","author":"YM Mosaad","year":"2015","unstructured":"Mosaad, Y. M. Clinical role of human leukocyte antigen in health and disease. Scand. J. Immunol. 82, 283\u2013306 (2015).","journal-title":"Scand. J. Immunol."},{"key":"79369_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2011.01.002","volume":"137","author":"J Trowsdale","year":"2011","unstructured":"Trowsdale, J. The MHC, disease and selection. Immunol. Lett. 137, 1\u20138 (2011).","journal-title":"Immunol. Lett."},{"key":"79369_CR5","doi-asserted-by":"crossref","unstructured":"Petersdorf, E.W. Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation. Version 1. F1000Res. 6, 617 (2017).","DOI":"10.12688\/f1000research.10990.1"},{"key":"79369_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fimmu.2017.00380","volume":"8","author":"R Gam","year":"2017","unstructured":"Gam, R. et al. Genetic association of hematopoietic stem cell transplantation outcome beyond histocompatibility genes. Front Immunol. 8, 380 (2017).","journal-title":"Front Immunol."},{"key":"79369_CR7","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","volume":"110","author":"SJ Lee","year":"2007","unstructured":"Lee, S. J. et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110, 4576\u20134583 (2007).","journal-title":"Blood"},{"key":"79369_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12185-013-1405-x","volume":"98","author":"J Kanda","year":"2013","unstructured":"Kanda, J. Effect of HLA mismatch on acute graft-versus-host disease. Int. J. Hematol. 98, 300\u2013308 (2013).","journal-title":"Int. J. Hematol."},{"key":"79369_CR9","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1182\/blood-2012-11-465161","volume":"121","author":"EW Petersdorf","year":"2013","unstructured":"Petersdorf, E. W. et al. Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation. Blood 121, 1896\u20131905 (2013).","journal-title":"Blood"},{"key":"79369_CR10","doi-asserted-by":"publisher","first-page":"e5228","DOI":"10.7717\/peerj.5228","volume":"6","author":"DP Chen","year":"2018","unstructured":"Chen, D. P. et al. Single nucleotide polymorphisms within HLA region are associated with disease relapse for patients with unrelated cord blood transplantation. PeerJ. 6, e5228 (2018).","journal-title":"PeerJ."},{"key":"79369_CR11","doi-asserted-by":"publisher","first-page":"13731","DOI":"10.1038\/s41598-019-50111-5","volume":"9","author":"DP Chen","year":"2019","unstructured":"Chen, D. P., Chang, S. W., Wang, P. N., Hus, F. P. & Tseng, C. P. Association between single nucleotide polymorphisms within HLA region and disease relapse for patients with hematopoietic stem cell transplantation. Sci Rep. 9, 13731 (2019).","journal-title":"Sci Rep."},{"key":"79369_CR12","doi-asserted-by":"crossref","unstructured":"Kulski, J.K. Long noncoding RNA HCP5, a hybrid HLA class I endogenous retroviral gene: structure, expression, and disease associations. Cells. 8, pii: E480 (2019).","DOI":"10.3390\/cells8050480"},{"key":"79369_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1399-0039.2005.00371.x","volume":"65","author":"SJ Soll","year":"2005","unstructured":"Soll, S. J., Stewart, B. S. & Lehman, N. Conservation of MHC class II DOA sequences among carnivores. Tissue Antigens 65, 283\u2013610 (2005).","journal-title":"Tissue Antigens"},{"key":"79369_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1034\/j.1399-0039.2002.590608.x","volume":"59","author":"TK Naruse","year":"2002","unstructured":"Naruse, T. K. et al. The HLA-DOB gene displays limited polymorphism with only one amino acid substitution. Tissue Antigens 59, 512\u2013519 (2002).","journal-title":"Tissue Antigens"},{"key":"79369_CR15","doi-asserted-by":"crossref","unstructured":"Song, N., Welsh, R.A., Sadegh-Nasseri, S. Investigating a role for HLA-DO in the development of CD4 memory cells. J Immunol. 202, 177.25 (2019).","DOI":"10.4049\/jimmunol.202.Supp.177.25"},{"key":"79369_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clim.2009.02.002","volume":"131","author":"D Lilleri","year":"2009","unstructured":"Lilleri, D. et al. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host. Clin. Immunol. 131, 395\u2013403 (2009).","journal-title":"Clin. Immunol."},{"key":"79369_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/BF00187095","volume":"32","author":"CM Milner","year":"1990","unstructured":"Milner, C. M. & Campbell, R. D. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32, 242\u2013251 (1990).","journal-title":"Immunogenetics"},{"key":"79369_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1099\/0022-1317-80-1-63","volume":"80","author":"E Ohgitani","year":"1990","unstructured":"Ohgitani, E., Kobayashi, K., Takeshita, K. & Imanishi, J. Biphasic translocation of a 70 kDa heat shock protein in human cytomegalovirus-infected cells. J. Gen. Virol. 80, 63\u201368 (1990).","journal-title":"J. Gen. Virol."},{"key":"79369_CR19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.2871","volume":"18","author":"M Rangachari","year":"2012","unstructured":"Rangachari, M. et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat. Med. 18, 1394\u20131400 (2012).","journal-title":"Nat. Med."},{"key":"79369_CR20","doi-asserted-by":"crossref","unstructured":"Pogge von Strandmann, E., Simhadri, V.R., von Tresckow, B. et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity. 27, 965\u2013974 (2007).","DOI":"10.1016\/j.immuni.2007.10.010"},{"key":"79369_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1096\/fj.11-189670","volume":"26","author":"N K\u00e4mper","year":"2012","unstructured":"K\u00e4mper, N. et al. \u03b3-Interferon-regulated chaperone governs human lymphocyte antigen class II expression. FASEB J. 26, 104\u2013116 (2012).","journal-title":"FASEB J."},{"key":"79369_CR22","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1128\/MCB.17.7.4105","volume":"17","author":"DP Satijn","year":"1997","unstructured":"Satijn, D. P. et al. RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor. Mol. Cell Biol. 17, 4105\u20134113 (1997).","journal-title":"Mol. Cell Biol."},{"key":"79369_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coi.2010.10.021","volume":"23","author":"FW McNab","year":"2011","unstructured":"McNab, F. W., Rajsbaum, R., Stoye, J. P. & O\u2019Garra, A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23, 46\u201356 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"79369_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00210-019-01788-y","volume":"393","author":"M Lei","year":"2020","unstructured":"Lei, M. et al. LncRNA HCP5 promotes LAML progression via PSMB8-mediated PI3K\/AKT pathway activation. Naunyn Schmiedebergs Arch. Pharmacol. 393, 1025\u20131032 (2020).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"79369_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12192-016-0676-6","volume":"21","author":"J Radons","year":"2016","unstructured":"Radons, J. The human HSP70 family of chaperones: where do we stand?. Cell Stress Chaperones. 21, 379\u2013404 (2016).","journal-title":"Cell Stress Chaperones."},{"key":"79369_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/carcin\/bgu224","volume":"36","author":"B Pardini","year":"2015","unstructured":"Pardini, B. et al. Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients. Carcinogenesis 36, 82\u201386 (2015).","journal-title":"Carcinogenesis"},{"key":"79369_CR27","first-page":"541531","volume":"2015","author":"X Song","year":"2015","unstructured":"Song, X. et al. A genetic variant in miRNA-219-1 is associated with risk of esophageal squamous cell carcinoma in Chinese kazakhs. Dis Markers. 2015, 541531 (2015).","journal-title":"Dis Markers."},{"key":"79369_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ydbio.2009.08.009","volume":"339","author":"T Juven-Gershon","year":"2010","unstructured":"Juven-Gershon, T. & Kadonaga, J. T. Regulation of gene expression via the core promoter and the basal transcriptional machinery. Dev Biol. 339, 225\u2013229 (2010).","journal-title":"Dev Biol."},{"key":"79369_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-genet-120116-024704","volume":"51","author":"C Mayr","year":"2017","unstructured":"Mayr, C. Regulation by 3-untranslated regions. Annu. Rev. Genet. 51, 171\u2013194 (2017).","journal-title":"Annu. Rev. Genet."},{"key":"79369_CR30","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/j.1365-2516.2009.02064.x","volume":"15","author":"T Yu","year":"2009","unstructured":"Yu, T. et al. Using a minigene approach to characterize a novel splice site mutation in human F7 gene causing inherited factor VII deficiency in a Chinese pedigree. Haemophilia 15, 1262\u20131266 (2009).","journal-title":"Haemophilia"},{"key":"79369_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fgene.2012.00055","volume":"3","author":"M Chorev","year":"2012","unstructured":"Chorev, M. & Carmel, L. The function of introns. Front Genet. 3, 55 (2012).","journal-title":"Front Genet."},{"key":"79369_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/j.1460-2075.1991.tb08044.x","volume":"10","author":"F Rippmann","year":"1991","unstructured":"Rippmann, F., Taylor, W. R., Rothbard, J. B. & Green, N. M. A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA. EMBO J. 10, 1053\u20131059 (1991).","journal-title":"EMBO J."},{"key":"79369_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.gene.2012.11.002","volume":"513","author":"Y Wei","year":"2013","unstructured":"Wei, Y. et al. Interaction between hypertension and HSP70 variants increase the risk of cerebral ischemia in Chinese Han population: an association study. Gene 513, 239\u2013243 (2013).","journal-title":"Gene"},{"key":"79369_CR34","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1128\/JVI.78.8.4054-4062.2004","volume":"78","author":"B Slobedman","year":"2004","unstructured":"Slobedman, B. et al. Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J. Virol. 78, 4054\u20134062 (2004).","journal-title":"J. Virol."},{"issue":"1121","key":"79369_CR35","first-page":"e9","volume":"21","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. Patients with refractory cytomegalovirus (CMV) infection following allogeneic hematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality. Clin. Microbiol. Infect. 21(1121), e9-15 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"79369_CR36","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00277-019-03682-2","volume":"98","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantation. Ann. Hematol. 98, 1765\u20131773 (2019).","journal-title":"Ann. Hematol."},{"key":"79369_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5500\/wjt.v8.i7.252","volume":"8","author":"M Damlaj","year":"2018","unstructured":"Damlaj, M. et al. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia\/lymphoma. World J. Transplant. 8, 252\u2013261 (2018).","journal-title":"World J. Transplant."},{"key":"79369_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/archderm.137.1.61","volume":"137","author":"R Valks","year":"2001","unstructured":"Valks, R. et al. Late appearance of acute graft-vs-host disease after suspending or tapering immunosuppressive drugs. Arch. Dermatol. 137, 61\u201365 (2001).","journal-title":"Arch. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79369-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79369-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79369-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T13:23:38Z","timestamp":1697549018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79369-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["79369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79369-w","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739373435.793582198","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1475"}}